Transplant Wellness Program
Launched by UNIVERSITY OF CALGARY · Apr 11, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Transplant Wellness Program (TWP) is a clinical trial designed to improve the health and well-being of patients undergoing kidney or liver transplantation. This program focuses on helping patients adopt healthy habits before and after their surgery, aiming to make their overall experience better. The TWP includes a 12-week exercise program tailored to each participant's needs, alongside support for nutrition, stress management, and sleep. By encouraging these positive lifestyle changes, the program hopes to enhance the quality of life for transplant patients, reduce hospital visits, and help them feel stronger both physically and mentally.
To be eligible for the TWP, participants must be 18 years or older and currently on the waiting list for a kidney or liver transplant. They should also be cleared by their doctor to engage in exercise and have access to the internet. Participants can expect to receive guidance and resources not only during the study but also for maintaining their wellness after the program ends. This trial is an opportunity for transplant patients to gain support in their journey to better health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years of age or older
- • In evaluation or listed (active or temporarily inactive) on the transplant waiting list (kidney or liver) - status 0, 1, or 2
- • Able to provide written informed consent and understand study information in English
- • Approval to exercise from Canadian Society for Exercise Physiology - Clinical Exercise Physiologist (CSEP-CEP)
- • Have access to an internet connected device
- Exclusion Criteria:
- • Not cleared for participation in the TWP by attending physician
- • Unable to provide informed consent
- • Clinical condition that makes the intervention unsafe or infeasible (e.g., unable to follow instruction due to refractory encephalopathy)
- • Unsafe environment for virtual participation
- • Recent variceal bleeding and cannot tolerate prophylaxis with non-selective beta blockers
About University Of Calgary
The University of Calgary is a leading research institution dedicated to advancing health and science through innovative clinical trials. With a strong emphasis on multidisciplinary collaboration, the university's clinical research initiatives aim to address pressing health challenges and improve patient outcomes. The institution fosters a robust environment for academic inquiry, leveraging state-of-the-art facilities and a diverse network of experts in various fields. Committed to ethical research practices and community engagement, the University of Calgary strives to translate scientific discoveries into tangible benefits for society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Calgary, Alberta, Canada
Patients applied
Trial Officials
Stefan Mustata, MD
Principal Investigator
University of Calgary
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported